Does REGORAFENIB Cause Product use issue? 129 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Product use issue have been filed in association with REGORAFENIB (Stivarga). This represents 1.4% of all adverse event reports for REGORAFENIB.
129
Reports of Product use issue with REGORAFENIB
1.4%
of all REGORAFENIB reports
21
Deaths
30
Hospitalizations
How Dangerous Is Product use issue From REGORAFENIB?
Of the 129 reports, 21 (16.3%) resulted in death, 30 (23.3%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which REGORAFENIB Alternatives Have Lower Product use issue Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR